Jack Lazar Sells 10,000 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Jack Lazar sold 10,000 shares of Astera Labs stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Trading Down 1.3%

NASDAQ:ALAB opened at $341.70 on Wednesday. Astera Labs, Inc. has a twelve month low of $84.78 and a twelve month high of $372.37. The company has a market cap of $58.57 billion, a price-to-earnings ratio of 230.88, a price-to-earnings-growth ratio of 4.59 and a beta of 3.95. The stock has a fifty day simple moving average of $222.18 and a 200-day simple moving average of $174.67.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the company earned $0.33 earnings per share. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: ALAB continues to benefit from bullish coverage tied to AI infrastructure growth, with recent commentary saying the company is still an early-stage AI story and that demand for its connectivity products remains strong. Astera Labs: Still An Early AI Story
• Positive Sentiment: Recent analysis highlighted that Astera Labs’ strong Q1 results, constructive Q2 guidance, and commentary around ramping products like Scorpio X-Series and PCIe offerings are helping support investor sentiment. Astera Labs jumps 9.4% as investors digest strong Q1 results and conference commentary
• Positive Sentiment: The company has also been included in speculation about potential future S&P 500 additions, which can draw extra attention from index-focused investors. Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500
• Neutral Sentiment: Astera Labs’ latest short-interest data was reported as essentially flat at zero shares, so this does not appear to be a meaningful trading catalyst.
• Neutral Sentiment: Shareholders approved directors and governance measures at the annual meeting, which is supportive of corporate housekeeping but unlikely to move the stock by itself. Astera Labs Shareholders Approve Directors and Governance Measures
• Negative Sentiment: Several pieces warned that ALAB’s valuation has become stretched after its rapid rally, increasing the risk of a pullback if growth expectations cool. Soaring Astera Labs stock faces a major valuation risk: what next?
• Negative Sentiment: Analyst commentary also turned more cautious, including a Seeking Alpha piece calling the stock a potential short candidate and another downgrade note advising investors to trim exposure. Astera Labs: I’d Short It, But There’s No Catalyst – Longs, Beware Astera Labs: Take Some Chips Off The Table (Rating Downgrade)
• Negative Sentiment: Director Jack Lazar sold 10,000 shares under a pre-arranged plan, adding to the market’s awareness that insiders have been frequent sellers in recent months. Astera Labs (NASDAQ:ALAB) Director Sells $3,551,700.00 in Stock

Analysts Set New Price Targets

Several analysts have recently weighed in on ALAB shares. Susquehanna lifted their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Morgan Stanley lifted their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Royal Bank of Canada raised its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares in the last quarter. Empowered Funds LLC raised its holdings in shares of Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares in the last quarter. First Trust Advisors LP raised its holdings in shares of Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after acquiring an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. raised its holdings in shares of Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.